These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9990606)

  • 1. The long QT syndrome and torsade de pointes.
    el-Sherif N; Turitto G
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):91-110. PubMed ID: 9990606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes.
    El-Sherif N; Turitto G
    Curr Opin Cardiol; 2003 Jan; 18(1):6-13. PubMed ID: 12496496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns.
    El-Sherif N; Chinushi M; Caref EB; Restivo M
    Circulation; 1997 Dec; 96(12):4392-9. PubMed ID: 9416909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired long QT syndrome and torsade de pointes.
    El-Sherif N; Turitto G; Boutjdir M
    Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital Long QT syndrome and torsade de pointes.
    El-Sherif N; Turitto G; Boutjdir M
    Ann Noninvasive Electrocardiol; 2017 Nov; 22(6):. PubMed ID: 28670758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Management of Athletes With Long QT Syndrome.
    Gomez AT; Prutkin JM; Rao AL
    Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
    Shimizu W; McMahon B; Antzelevitch C
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of ventricular arrhythmias in the long QT syndrome: on hermeneutics.
    El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Aug; 12(8):973-6. PubMed ID: 11513452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.
    Akar FG; Yan GX; Antzelevitch C; Rosenbaum DS
    Circulation; 2002 Mar; 105(10):1247-53. PubMed ID: 11889021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycle length-associated modulation of the regional dispersion of ventricular repolarization in a canine model of long QT syndrome.
    Chinushi M; Caref EB; Restivo M; Noll G; Aizawa Y; El-Sherif N
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1247-57. PubMed ID: 11523611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of pause-induced torsade de pointes in long QT syndrome.
    Liu J; Laurita KR
    J Cardiovasc Electrophysiol; 2005 Sep; 16(9):981-7. PubMed ID: 16174020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of sudden death in congenital long-QT syndrome].
    Oliveira M; Antunes E; da Silva MN
    Rev Port Cardiol; 1999 Jun; 18(6):627-33. PubMed ID: 10422460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.